Supplementary Figure 8 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
Year: 2025
Type: supplementary-materials
Abstract: Kaplan-Meier survival curve with a mixed group infused with 50% CD229-VLVH-BBζ + 50% ARI0002h
Authors: Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol, Anthony M. Battram, Sergi Vaqué-Salsench, Judith Carpio, Lorena Pérez-Amill, Hugo Calderón, Beatriz Martín-Antonio, Aina Oliver-Caldés, Ester Lozano, David F. Moreno, Valentin Ortiz-Maldonado, Maria Queralt Salas, Anna de Daniel, Natalia Tovar, M. Teresa Cibeira, Laura Rosiñol, Joan Bladé, Manel Juan, Álvaro Urbano-Ispizua, Pablo Engel, Carlos Fernández de Larrea
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4413906830